Does Rallies show ENGN 10-K and 10-Q filings?

Rallies organizes ENGN SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.

Is ENGN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ENGN. It does not provide personalized investment advice.

ENGN (enGene Therapeutics Inc. Common Stock) Stock Analysis - SEC Filings

enGene Therapeutics Inc. Common Stock (ENGN) is a publicly traded Healthcare sector company. As of May 21, 2026, ENGN trades at $1.55 with a market cap of $105.17M and a P/E ratio of 0.70. ENGN moved +5.88% today. Year to date, ENGN is -81.56%; over the trailing twelve months it is -61.67%. Its 52-week range spans $1.40 to $12.25. Analyst consensus is buy with an average price target of $8.69. Rallies surfaces ENGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find ENGN SEC filings?

Rallies organizes ENGN SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

ENGN Key Metrics

Key financial metrics for ENGN
Metric	Value
Price	$1.55
Market Cap	$105.17M
P/E Ratio	0.70
EPS	$2.29
Dividend Yield	0.13%
52-Week High	$12.25
52-Week Low	$1.40
Volume	1.16K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-117.30M
Gross Margin	0.00%

Latest ENGN News

Analysts Slash enGene Price Targets 40% After ENG-1 Trial Misses Endpoints — May 8, 2026
enGene Hits 62% CR in 125-Patient LEGEND Trial, Plans BLA by End-2026 — Feb 28, 2026

Recent ENGN Insider Trades

Forbion Growth Opportunities Fund I Cooperatief U.A. bought 561.80K (~$5.00M) on Oct 30, 2024.
Forbion Growth Opportunities Fund I Cooperatief U.A. bought 800 (~$5.28K) on Oct 8, 2024.
Forbion Growth Opportunities Fund I Cooperatief U.A. bought 11.84K (~$77.53K) on Oct 7, 2024.

ENGN Analyst Consensus

12 analysts cover ENGN: 0 strong buy, 4 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.69.

Common questions about ENGN

Where can I find ENGN SEC filings?: Rallies organizes ENGN SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show ENGN 10-K and 10-Q filings?: Rallies organizes ENGN SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is ENGN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ENGN. It does not provide personalized investment advice.